Crystal Pharmatech
ent_7fb10fa1bf482280d46c95ae
Disclosures
3
Leak Site · 1 jurisdiction
Multi-filing incidents
—
no multi-filing incident in sample
Max affected reported
—
no filed count in sample
Leak-site claims
3
unverified actor claims
Identity resolution
- Canonical name
- Crystal Pharmatech
- Normalized
- crystal pharmatech— dedupe via name-norm; Microsoft / MSFT collapse to one row
- GLEIF LEI
- No match
- SEC EDGAR CIK
- None — not an SEC registrant
- Domain
- crystalpharmatech.com
Unverified threat-actor claim — not a regulatory filing
Attribution, victim identity, and counts shown here derive from a threat actor's public extortion-blog claims, aggregated by ransomware.live. They have not been validated by the victim or any regulator. Treat them as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Disclosure history (3)newest first
- GLOBALLeak Siteas victim2026-08-30
- GLOBALLeak Siteas victim2026-08-21
Crystal Pharmatech is a technology-driven contract research organization (CRO) that focuses on materials science and engineering for drug development. Established in 2010 and have R&D centers located in Suzhou (China), New Jersey, San Francisco (USA), and Toronto (Canada). Also its key differentiator is integrated and specialized services, including API solid-state research, crystallization, preformulation, formulation development and manufacturing, clinical supply.
- GLOBALLeak Siteas victim2026-08-06